As proof of the principle that TGF-β1 and PDGF are the central mediators of tissue fibrosis in SSc [19, 34], we selected these two stimulators to establish in vitro models to analyze the antifibrotic activity of baicalein. The gene discussed is TGFB1; the disease is systemic sclerosis.